A recent multicenter analysis compared salpingectomy with vasectomy as strategies for permanent contraception in the U.S, modelling outcomes in a cohort of 800,000 individuals. Results showed vasectomy remains more cost-effective (ICER $143,769/QALY) at a willingness-to-pay threshold of $100,000 . However, salpingectomy demonstrated significant long-term health advantages, preventing over 1,200 unintended pregnancies, more than 6,000 ovarian cancer cases, and nearly 5,000 ovarian cancer–related deaths annually. These findings highlight a clinical dilemma—while vasectomy offers cost savings, salpingectomy could contribute meaningfully to cancer prevention and women’s long-term health.
To read more; Click here Should cost or cancer prevention drive the choice in permanent contraception? ##Reference## Pearson, Amy BS; Shvartsman, Katerina MD; Zeng, Wu MD, PhD; Brown, Jill MD, MPH. Cost…
